-
CADE leads an investigation in public procurement for drugs acquisition
-
The charged parties will be notified to present their defenses.
by assint
published
em
Apr 02, 2015
—
last modified
em
Apr 11, 2016 02:58 PM
filed under:
cartel,
public bids,
aquisitions,
medicines,
administratif proceeding,
General Superintendence
-
Eli Lilly fined in BRL 36.6 million for sham litigation
-
The company omitted information about the administrative process in the National Institute of Industrial Property (INPI in its acronym in Portuguese), and a series of relevant information about the change of scope in the patent request.
by assint
published
em
Jun 25, 2015
—
last modified
em
Apr 08, 2016 10:40 AM
filed under:
condemnation,
tribunal,
eli lilly,
sham litigation,
administratif proceeding,
medicines,
distrito federal,
rio de janeiro,
São Paulo
-
General Superintendence concluded opinion on acquisition of Genix by Capsugel
-
CADE’s Tribunal, which will be responsible for the final decision on the approval, blockage or adoption of eventual remedies
by assint
published
em
Mar 23, 2015
—
last modified
em
Apr 11, 2016 03:44 PM
filed under:
institutional,
aquisition,
genix,
capusel,
General Superintendence,
mergers,
medicines
-
CADE fines cartel in the market of generic medicines in BRL 4.2 million
-
Majority of the council voted for the condemnation of pharmaceutical laboratory
by assint
published
em
Aug 07, 2014
—
last modified
em
May 02, 2016 05:57 PM
filed under:
Cartel,
medicines,
generic medicines,
merck
